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DNA methylation is one of a number of modes of
epigenetic gene regulation. Here, we profile the DNA
methylome, transcriptome, and global occupancy
of histone modifications (H3K4me1, H3K4me3,
H3K27me3, and H3K27ac) in a series of mouse
embryonic stem cells (mESCs) with varying DNA
methylation levels to study the effects of DNAmethyl-
ation on deposition of histone modifications. We find
that genome-wide DNA demethylation alters occu-
pancy of histone modifications at both promoters
and enhancers. This is reversed upon remethylation
by Dnmt expression. DNA methylation promotes
H3K27me3 deposition at bivalent promoters, while
opposing H3K27me3 at silent promoters. DNA
methylation also reversibly regulates H3K27ac and
H3K27me3 at previously identified tissue-specific en-
hancers. These effects require DNMT catalytic activ-
ity. Collectively, our data show that DNA methylation
is essential and instructive for deposition of specific
histone modifications across regulatory regions,
which together influences gene expression patterns
in mESCs.
INTRODUCTION
Recent studies have revealed that global DNA methylation is
dramatically altered during pre- and post-implantation develop-
ment (Guo et al., 2014; Smith et al., 2014), primordial germ cell
reprogramming (Gkountela et al., 2015; Guo et al., 2015b;
Tang et al., 2015), as well as stem cell differentiation (Xie et al.,
2013) and cellular reprogramming (Lister et al., 2011). A major
challenge in the field has been to understand how drastic
changes in methylomes contribute to altered transcriptional pro-
grams associated with cell-fate commitment and differentiation.Cell Re
This is an open access article undThe prevailing hypothesis posits that DNA methylation is a
crucial silencer of pluripotency and tissue-specific genes via
promoter hypermethylation. However, gene promoters account
for a tiny fraction of the genome, and increasing evidence
repudiates the obligate role for promoter methylation in gene
silencing (Bogdanovic et al., 2011; Hammoud et al., 2014; Noh
et al., 2015). For instance, pluripotency genes can be silenced
during differentiation in the absence of promoter methylation
(Sinkkonen et al., 2008). Therefore, it is becoming increasingly
clear that DNA methylation works in conjunction with other fac-
tors to properly regulate gene expression (Fouse et al., 2008).
DNAmethylation and histone modifications are two mediators
of epigenetic regulation. These two marks cooperate at many
times during development, including silencing of pluripotency
genes, genomic imprinting, and X chromosome inactivation (Ce-
dar and Bergman, 2009). Currently, two models describe the
relationship between DNA methylation and histone modifica-
tions. A number of studies support the idea that DNAmethylation
is targeted and patterned by histone modifications in the ‘‘fol-
lower’’ model, where DNA methylation acts downstream in the
regulatory hierarchy. For example, de novo DNA methyltrans-
ferases (DNMT) are shown to recognize unmethylated histone
H3 (H3K4me0) at promoters specifying methylation patterns at
promoters (Guo et al., 2015a; Ooi et al., 2007; Otani et al.,
2009; Zhang et al., 2010). Similarly, H3K36me3 has recently
been shown to target DNMT3B to gene bodies contributing to
genic methylation (Baubec et al., 2015; Morselli et al., 2015).
Alternatively, mounting evidence argues for an instructive role
for DNA methylation that regulates histone modification pat-
terns, acting higher in the hierarchy. Under certain circum-
stances, DNA methylation has been found to be antagonistic
to H3K27me3 at promoters. At these sites, methylated DNA is
found to exclude binding of PRC2 components to their targets,
providing a mechanistic basis for mutual exclusion (Bartke
et al., 2010; Jermann et al., 2014). In addition, DNMT3A enzyme
was found to facilitate neurogenic gene expression through the
exclusion of Polycomb protein binding in gene bodies (Wu
et al., 2010). In short, the complex relationship between DNAports 17, 289–302, September 27, 2016 ª 2016 The Author(s). 289
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methylation and histone modifications remains to be illustrated,
possibly in a cell-type and/or genomic region-specific manner.
To understand how DNAmethylation may coordinate with his-
tone modifications to regulate genome-wide gene expression,
we and others have leveraged hypomethylated mouse embry-
onic stem cells (mESCs), which are viable despite complete
loss of genomic DNA methylation. We have previously found
that mESCs null of DNA methylation show upregulation of
genes primarily associated with bivalent (H3K4me3/H3K27me3
positive) or unmarked (H3K4me3/H3K27me3 double negative)
gene promoters inwild-type cells (Fouse et al., 2008). In contrast,
minimal changes in H3K9me3 occupancy were observed in hy-
pomethylated mESCs, leading to the idea that DNA methylation
and H3K9me3 act non-redundantly (Karimi et al., 2011). Mean-
while, H3K27me3 is dramatically redistributed in response to
DNA hypomethylation (Brinkman et al., 2012; Cooper et al.,
2014; Reddington et al., 2013). Despite these findings, it is still
inconclusive whether the changes of histone modifications
observed in DNA methylation null mESCs are directly or indi-
rectly caused by hypomethylation.
In this current study, we set out to understand how DNA
methylation shapes the histone landscape and transcriptome
in mESCs. To study this, we employed sets of mESC with fully
methylated and globally demethylated genomes, or with various
intermediate levels of hypomethylation followed by subsequent
measurement of histone modifications and RNA transcriptome
across all states. Thus, our experimental setup is designed
to determine whether DNA methylation acts upstream or
downstream with respect to several histone modifications. We
show that DNA methylation reversibly regulates occupancy of
H3K27me3 and H3K27ac at both gene promoters and tissue-
specific enhancer elements. Indeed, changes in H3K27me3
and H3K27ac histone modifications are reversed upon DNMT
reconstitution, dependent on DNMT catalytic activity, indicating
the ability of DNA methylation to outcompete established chro-
matin states.
RESULTS
Dnmt Reconstitution in Demethylated mESCs Restores
Global Cytosine Methylation and Causes Various
Changes in Histone Modifications
To dissect causal relationships between DNA methylation and
histone modifications, we simultaneously knocked out all three
DNA methyltransferases, Dnmt1, Dnmt3a, and Dnmt3b via
Cre-lox recombination to generate triple Dnmt knockout (TKO)
mouse embryonic stem (ES) cells that are completely devoid of
DNA methylation after several cell passages (Figure 1A). By
contrast, double knockout (DKO) of the de novo DNA methyl-
transferases Dnmt3a and Dnmt3b leads to slower global deme-
thylation (presumably due to the robust Dnmt1 maintenance
enzyme) and reaches 90% loss of global methylation by 30
passages (Jackson et al., 2004) (Figure 1B). In these two deme-
thylated mESC systems, we then reconstituted Dnmt3a1,
Dnmt3a2, and Dnmt3b1 isoforms individually (Figures 1A and
S1A). Reconstitution of the de novo DNMTs in TKO mESCs re-
sulted in increased global methylation to approximately half of
wild-type (WT) levels (Figure 1B). In DKO mESCs, reconstitution290 Cell Reports 17, 289–302, September 27, 2016of Dnmt3a1, Dnmt3a2, or Dnmt3b1 led to a greater increase of
methylation to >70%WT levels, indicating a significant contribu-
tion fromDnmt1. Profiling the DNAmethylomes of TKO and DKO
reconstitution cell lines using reduced representation bisulfite
sequencing (RRBS) showed global levels of cytosinemethylation
consistent with mass spectrometry results (Figures 1B and S1B).
Together, these cell lines enable the study of relationships be-
tween varying global methylation levels and histone occupancy.
Mapping average methylation across all genes, we find similar
methylation distribution patterns, but different amplitudes pro-
portional to global methylation levels (Figure S1C). Inspection
of individual CpG sites revealed that the amplitude differences
between cell lines are explained by cytosines being partially
methylated rather than a skewed distribution of fully methylated
and unmethylated CpGs (Figure S1B). Together, our data sug-
gest that Dnmt3a and Dnmt3b isoforms are all capable of
shaping the overall DNA methylome patterning.
Using chromatin immunoprecipitation sequencing (ChIP-seq),
we profiled genomic occupancy of H3K4me3, associated with
active promoters, H3K27me3 associated with repressive chro-
matin, H3K27ac, associated with active promoters and en-
hancers (Creyghton et al., 2010), and H3K4me1, associated
with regulatory regions including enhancers (Barski et al.,
2007; Heintzman et al., 2007). Comparison across WT, TKO,
DKO, and Dnmt reconstitution cell lines reveals selective
global changes in specific histone modifications. Genome-
wide correlation between all histone modifications and cell
lines revealed that correlation generally exists among each
histone modification. For example, H3K4me3 across samples
are highly correlated (Pearson correlation, r > 0.96) (Figure 1C),
indicating that H3K4me3 is largely unaffected by global
hypomethylation.
Among H3K27ac datasets, inter-sample correlation is also
high (r 0.93); however, there may be few site-specific differ-
ences resulting from hypomethylation. By contrast, H3K27me3
appears to be most sensitive to varying levels of global DNA
methylation. WT have 0.63 and 0.65 Pearson correlation with
TKO and DKO respectively, >0.7 correlation with reconstitution
in TKO and >0.8 correlation with reconstitution in DKO (Fig-
ure 1C, lower-left corner). Correlations are also seen between
histone modifications, for example between H3K4me1 and
H3K27ac (r 0.40) and between H3K27me3 and H3K4me3 in
WT (r 0.18), suggesting co-localization in a significant portion
of the genome. Epigenetic profiling across mESC lines of
different global methylation states is shown at several genomic
loci, illustrating histone modification changes sensitive to DNA
methylation (Figure 1D). Overall, this indicates a broad role
for DNA methylation in influencing histone modifications, with
different histone modifications showing different relationships.
DNA Methylation Is Required for Maintenance and
Re-establishment of Promoter H3K27me3
Aswe observed the greatest global variation in H3K27me3 occu-
pancy in response to DNA hypomethylation, we aimed to further
investigate the relationship between DNA methylation and
H3K27me3 at promoters. We first organized promoters by chro-
matin environment, categorizing promoters into H3K4me3+,
bivalent, H3K27me3+, and silent devoid of both H3K4me3 and
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Figure 1. Alterations of DNA Methylation Cause Selective Genome-wide Changes in Histone Modifications
(A) Schematic of experimental design. Wild-type, TKO, DKO, and Dnmt Reconstitution cell lines each are assayed for DNA methylation by RRBS, histone
modifications by ChIP-seq, and gene expression using RNA-seq.
(B) Left: mass spectrometry measurement of global 5mC levels between WT (n = 6), TKO (n = 7), TKO+Dnmt3a1 (n = 5), TKO+Dnmt3a2 (n = 6), TKO+Dnmt3b1
(n = 4), and DKO and reconstitution cell lines (n = 2). Data are represented as mean ± SEM. Right: global 5mC levels measured by RRBS.
(C) Global Pearson correlation analysis between H3K27me3, H3K4me1, H3K4me3, and H3K27ac histone modifications across mESC lines. Correlation was
calculated based on 1 kb genome-wide bins.
(D) Genome browser tracks of RRBS and histone modification ChIP-seq between WT, KO, and Dnmt reconstitution mESC lines. Regions of interest exhibiting
histone modification changes are boxed.H3K27me3 histonemodifications (Fouse et al., 2008) (Figure 2A).
Consistent with previous studies, we find that H3K27me3 is
reduced at nearly all bivalent promoters (3,231/5,362 = 60.3%)
in demethylated mESCs (Brinkman et al., 2012; Cooper et al.,
2014) (Figures 2A and 2B). The loss of H3K27me3 at bivalent pro-
moters is also associated with a small gain in H3K27ac and loss
of H3K4me1 at a subgroup of promoters (Figures S2A–S2C). In
contrast, for a subgroup of silent promoters (H3K4me3 and
H3K27me3 negative) (705/9,068 = 7.8%), we find increased
H3K27me3 occupancy in the demethylated state. For example,
promoters of Cdkn2a and Pdgfb are bivalently marked and
upon demethylation and entirely lose H3K27me3 (Figure 2C). In
the case of Cdkn2a, the promoter is seen to gain H3K27ac. In
contrast, Trpv1, which is devoid of H3K4me3 and H3K27me3,gains H3K27me3 upon demethylation (Figure 2C). Interestingly,
this increase of H3K27me3 extends to adjacent regions in-
cluding the gene body. Together, these data indicate that DNA
methylation is necessary for the maintenance of normal pro-
moter H3K27me3 patterns in a context-specific manner.
We next asked whether DNA methylation can re-establish
normal H3K27me3 patterns by reconstituting Dnmt in demethy-
lated mESCs. Expression of Dnmt3a1, Dnmt3a2, and Dnmt3b1
in TKOandDKOmESCs restores variable levels ofH3K27me3oc-
cupancy around promoters (Figures 2A and 2D). At bivalent pro-
moters,Dnmt3a1 andDnmt3a2 appear to have a slightly stronger
impact in restoring H3K27me3 compared to Dnmt3b1. Nonethe-
less, neither of the three enzymes alone could fully recapitulate
WT patterns when reconstituted in TKO mESCs (Figure S2D). ByCell Reports 17, 289–302, September 27, 2016 291
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Figure 2. DNA Methylation Causally Regulates the Maintenance and Establishment of Promoter H3K27me3
(A) Heatmap of H3K4me3 (red) and H3K27me3 (blue) at ±5 kb region centered around all Refseq TSS ranked by H3K4me3. Promoter categories are shown on left.
Representative genes from bivalent and silent promoter categories are shown on the right.
(B) Comparison of H3K27me3 between TKO versus WT at bivalent (top) and silent (bottom) promoters. Gray dots include all promoters and colored dots are
statistically different between TKO and WT (p < 0.0001). Data are represented as H3K27me3 read coverage in log-transformed tags per 10 million (TPM) reads
within 2 kb surrounding TSS of individual promoters.
(C) Genome browser tracks showing gene model, CpG islands, RRBS DNA methylation, H3K27me3/H3K27ac, and H3K4me1 (from top to bottom) at different
loci. Promoter regions of Cdkn2a and Pdgfb (bivalent) and Trpv1 (silent) are shown boxed.
(D) H3K27me3 occupancy in WT, demethylated DKO, and remethylated Dnmt reconstitution lines. Promoter metaplot and boxplot quantification of H3K27me3
occupancy between cell lines for bivalent (left) and silent (right) promoters. Metaplot represented as normalized H3K27me3 reads (in tags per 10 million; TPM)
measured in 100 bp bins across ±5 kb centered at TSS. Boxplot data are similarly represented as H3K27me3 TPM within 2 kb surrounding TSS.
(E) Comparison of fractional CpG methylation and observed-to-expected CpG ratio between bivalent and silent promoters in 2 kb surrounding TSS (top).
Promoter metaplot showing average CpG methylation at ±5 kb region centered around TSS (bottom).
(F) Promoter H3K27me3 correlates with global DNA methylation (measured by mass spec) at bivalent and silent promoters. Data are represented as normalized
H3K27me3 in TPM within 5 kb of promoters and global 5mC (as in Figure 1B) are shown for each cell line. H3K27me3 TPM represents an average across all
bivalent and silent promoters respectively. Note that the y axis scale is different between bivalent and silent promoters.
(G) Reads per kilobase million reads (RPKM) expression values for individual genes (left) and all bivalent and silent promoters (right). Bivalent promoters are
expressed at a higher level in DKO relative to WT (p = 4.75 3 10–7, Kolmogorov-Smirnov test).
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contrast, reconstitution of Dnmt3a1, Dnmt3a2, and Dnmt3b1 in
DKO mESCs shows greater H3K27me3 rescue, particularly
Dnmt3a1, which showsH3K27me3patterns/levels phenocopying
WT(Figures2Aand2D).Meanwhile, atsilentpromoters,wherede-
methylation leads to increased levels of H3K27me3 occupancy,
we also observe differences in rescue between TKO and DKO
reconstitution cell lines. Whereas TKO Dnmt reconstitution ap-
pears to have weak rescue of H3K27me3 at silent promoter, all
Dnmt isoforms in DKO are able to restore H3K27me3 down to
nearWT levels (Figures 2D andS2D). Thesedata show that recon-
stituted DNMT is capable of re-establishingWT histone modifica-
tionpatterns, indicatingDNMT’sability tooutcompeteestablished
chromatin states (i.e., the demethylated epigenome) at gene
promoters.
Impact of DNA Methylation on Promoter H3K27me3 and
Gene Expression Differs between Bivalent and Silent
Promoters
To determine the role of DNA methylation in regulation of his-
tone modifications at promoters, we quantified methylation in
different categories of promoters (Figure 2E, top). Bivalent pro-
moters are hypomethylated with an average methylation fraction
of 0.17, while silent promoters are hypermethylated with an
average of 0.88 (Figure 2E). As CpG islands are frequently found
at gene promoters and are hypomethylated, we measured the
CpG content of promoters in each category, represented as
CpG observed-to-expected ratio (CpG O/E). We find bivalent
promoters are CpG-rich (O/E >0.6), consistent with the associa-
tion of bivalent promoters with CpG islands (Bernstein et al.,
2006). Silent promoters that gain H3K27me3 are characterized
by lowCpG content (O/E <0.4), consistent with lowCpG-content
promoters (LCPs) being predominately methylated in mESCs
(Fouse et al., 2008; Weber et al., 2007). Analysis of DNA methyl-
ation in KO and reconstitution cell lines shows loss and recovery
of WT methylation levels and patterns (Figure 2E, bottom). Biva-
lent promoters, such asCdkn2a and Pdgfb, showed a character-
istic hypomethylated CpG island surrounding the transcriptional
start site (TSS), while silent promoters, such as Trpv1, were
heavily methylated (Figures 2C and 2E).
Comparing average H3K27me3 occupancy at transcriptional
start sites with global 5mC between cell lines reveals strong as-
sociations between DNA methylation and promoter H3K27me3
(Figure 2F). Average H3K27me3 positively correlates with global
DNA methylation at bivalent promoters (Pearson correlation, r =
0.84), whereas H3K27me3 is anti-correlated with global DNA
methylation at silent promoters (r = 0.95) (Figure 2F). These
data suggest a predictive ability of global DNAmethylation levels
on H3K27me3 occupancy in two promoter contexts.
To test whether alterations in histone modification resulting
from demethylation induce any change in gene expression, we
profiled the transcriptome from all cell lines. Genes with bivalent
promoters generally had low expression (RPKM <10) but signifi-
cantly increased (mean RPKM increase from 3.9 to 4.8) upon de-
methylation (Figure 2G). Alternatively, silent promoters were not
expressed (RPKM <1) and on average remained silenced despite
demethylation. In the case of bivalent promoter geneCdkn2a, we
saw gene expression increase over 2-fold in DKO with re-sup-
pression upon remethylation in Dnmt reconstitution mESCs.DNAMethylation Maintains and Re-establishes Silent or
Primed States at Enhancer Elements
Differential DNA methylation is prevalent at tissue-specific en-
hancers (Andersson et al., 2014; Elliott et al., 2015; Hon et al.,
2013; Stadler et al., 2011; Thurman et al., 2012; Ziller et al.,
2013), suggesting a regulatory role for DNA methylation at
enhancer elements. We therefore extended our analysis to en-
hancers, analyzing H3K27ac/me3 and H3K4me1 modifications
(Heintzman et al., 2007). We predicted that genomic hypo-
methylation would lead to activation of silent enhancers either
as appearance of active enhancers (marked with both
H3K27ac and H3K4me1) or as poised enhancers (marked with
H3K27me3 and H3K4me1) in TKO (Figure 3A) (Creyghton
et al., 2010; Rada-Iglesias et al., 2011; Zentner et al., 2011).
To identify putative methylation-dependent enhancer sites, we
identified differentially enriched peaks between demethylated
DKO/TKO and their respective methylated wild-type mESCs. Dif-
ferential peaks were overlapped with H3K4me1 and those within
2 kb of known TSS were excluded to avoid identification of gene
promoters. Identifying differential peaks common to both DKO
and TKO yielded a number of changes in the chromatin state of
candidate enhancers upon genomic hypomethylation (Figure 3A).
For example, we observed 138 (1.3%) and 551 (5.2%) peaksgain-
ing and losing H3K27ac, respectively. Similarly, we found 1,041
(46.5%) peaks gained and 162 (7.2%) peaks lost H3K27me3 in
response to global demethylation. We noted that candidate en-
hancers that become active or poised in Dnmt KO mESCs pre-
dominately arise de novo from previously primed enhancer loci
in WT mESCs (Figure 3B). Few new active or poised enhancers
derive from the other indicating thatmethylation does not regulate
transitions between active and poised status.
We then sought to determine whether or not remethylation
would be able to return the enhancers to their original state. If
chromatin state takes precedence over DNA methylation, we
would expect histone modification status of reconstituted cell
lines to resemble the demethylated state. On the other hand, if
DNA methylation is capable of acting upstream in the hierarchy,
the chromatin state would be reversible. We find that for both
H3K27ac and H3K27me3, re-establishing DNA methylation re-
turns putative enhancers to the wild-type state, exemplified by
de novo intergenic active enhancer upstream of Foxd3 as previ-
ously characterized in TKOmESCs (Domcke et al., 2015), and an
intragenic poised enhancer in Tmem104 (Figure 3C). The histone
modification changes characterized in demethylated DKO and
TKO mESCs were uniformly reversible across all enhancers
identified (Figures 3D and S3). Similar to rescue at promoters,
Dnmt reconstitution in DKO more efficiently re-establishes
wild-type patterns of enhancers compared to in TKO (Figure 3D).
Enhancers that tend to lose H3K27ac or H3K27me3 are rela-
tively hypomethylated in WT mESCs, whereas enhancers that
gain H3K27ac or H3K27me3 are relatively hypermethylated (Fig-
ure 3E). This is consistent with antagonism between modifica-
tions of the H3K27 residue with DNA methylation (Bartke et al.,
2010; Jermann et al., 2014). Measuring CpG content, all en-
hancers sensitive to DNA methylation consistently show low
CpG O/E (O/E <0.4) (Figure 3E). In contrast with CpG-rich biva-
lent promoters that lose H3K27me3, poised enhancers losing
H3K27me3 are low in CpG content.Cell Reports 17, 289–302, September 27, 2016 293
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Figure 3. DNA Methylation Regulates Histone Modifications and Active States at Enhancers
(A) Altered histone modification occupancy at putative enhancer sites. Metaplot indicates H3K27ac and H3K27me3 read coverage from DKO (solid) and TKO
(dashed), normalized by depth in 100 bp bins within ±5 kb around non-promoter H3K4me1 peaks.
(B) Schematic showing changes in candidate enhancer status between primed (H3K4me1+), active (H3K4me1+/H3K27ac+), and poised (H3K4me1+/H3K27me3+)
states. Numbers in circles indicate number of sites in WT mESC. Arrows represent changes occurring with demethylation in DKO/TKO.
(C) Genome browser visualization of histone modification changes at candidate de novo active (chr4:99,210,711-99,257,661; 80 kb upstream of Foxd3) and
poised (chr11:115,049,693-115,089,693; Tmem104 intragenic) enhancer sites.
(D) Heatmap analysis of histone modification changes toDnmtDKO/TKO and reconstitution. Heatmap shows H3K4me1, H3K27ac, H3K27me3, and 5mCpG ±5 kb
genomic region centered on H3K4me1 separated by candidate enhancer categories: H3K27ac gain (n = 138), H3K27ac loss (n = 551), H3K27me3 gain (n = 1,041),
H3K27me3 loss (n = 162).
(legend continued on next page)
294 Cell Reports 17, 289–302, September 27, 2016
Lastly, to test whether chromatin state at enhancers alters
gene expression, we measured gene expression at both
genes nearest to each enhancer (data not shown), as well as a
subset of promoters with previously confirmed Hi-C interactions
with DNA methylation-sensitive enhancers we identified (Shen
et al., 2012). Expression changes at genes associated with
methylation-sensitive enhancers varied in their response to
demethylation, where each category included genes up- and
downregulated (Figure 3F). Median fold change within enhancer
categories indicated nearly equal up- and downregulation. How-
ever, several genes exhibit expression patterns indicative of
regulation by enhancer methylation. In the case of Elmo1, gene
expression increased greater than 2-fold in association with a
de novo active enhancer within the first intron (Figure 3G).
Reconstitution of Dnmt also returned both expression of Elmo1
as well as the intragenic enhancer to wild-type levels. Together,
this shows that there are hundreds of enhancers in mESCs
where DNA methylation is the primary factor in determining the
modification status of chromatin.
De Novo Enhancers Are Tissue Specific and Contain
Methylation-Sensitive Transcription Factor Binding
Motifs
To characterize DNA methylation-sensitive enhancers, we cross-
referenced these enhancers with previously identified tissue-spe-
cific enhancers to assess their identity (Shen et al., 2012) (Fig-
ure 4A). Of the active enhancers that significantly gain or lose
H3K27ac upon DNA demethylation, 33.3% (46/138) and 40.8%
(225/551) overlappedwith tissue-specific enhancers respectively.
In both categories, mESC-specific enhancers were found, with
nearly two-thirds of active enhancers losing H3K27ac predictably
consisting of mESC-specific enhancers. De novo active en-
hancers that gained H3K27ac showed overlap with several
testes, liver, placenta, and kidney-specific enhancers, with the
remainder divided between 14 other tissues (Figure 4A). Both en-
hancers that gain and lose H3K27me3 also overlapped with tis-
sue-specific enhancers showing 33.2% (346/1,041) and 23.5%
(38/162) overlap respectively. Interestingly, de novo poised en-
hancers overlap with previously identified enhancers from a
variety of different tissue types. Meanwhile, enhancers losing
H3K27me3 are predominately specific to testes (76%), with a
smaller contribution from other tissue types.
To determine how DNA methylation regulates enhancers, we
assessed DNA methylation-sensitive enhancers for enrichment
of transcription factor motifs. We focused on enhancers gaining
H3K27ac or H3K27me3, representing de novo active or poised
enhancers, as sites losing these marks are already active/
poised and are predictably enriched in pluripotency factors
(Figure S4). We find that de novo active enhancers (gain
H3K27ac in Dnmt KO) are strongly enriched in motifs for
NRF1 (16%) and Nkx family transcription factors (87%) (Fig-
ure 4B). Interestingly, NRF1 was recently described to be a(E) Comparison of fractional CpG methylation (top) and observed-to-expected C
DNA methylation-sensitive enhancers.
(F) Distribution of log2 fold change (DKO/WT) in gene expression (in RPKM) betw
(G) Representative example of gene expression changes at Elmo1 (chr13:20,175,
labeled with E) and expression in DKO and reversion with Dnmt reconstitution.DNA methylation-dependent transcription factor where methyl-
ation of CpG within the binding motif affected binding to
DNA (Domcke et al., 2015). In our data, we identified several
instances of de novo methylation-dependent active enhancers
with underlying methylated NRF1 motifs (Figure 4C). For ex-
ample, at a testes-specific enhancer upstream of Zfp92, we
find a DNA methylation-dependent peak with adjacent Nkx2.5
and NRF1 motifs. NRF1 at this enhancer is methylated at an in-
termediate level (0.29-0.57) in mESCs and is specifically deme-
thylated (<0.05) in adult germline stem cells (AGSCs) of the
testis (Hammoud et al., 2014). Similarly, a placenta-specific
enhancer is found intragenically in Ears2, where a local NRF1
motif is methylated (0.83) in mESCs. The motif for ZBTB33
(also known as Kaiso), a transcriptional regulator described to
bind methylated CGCG motif in vitro, was also found at six
sites (4.4%).
At de novo poised enhancers (gain H3K27me3 in Dnmt KO),
we find enrichment of several motifs containing the canonical
E box sequence CACGTG as well as motifs for pluripotency
factor Esrrb (Figure 4B). Notably, Myc and Max were also iden-
tified as putative methylation-dependent transcription factors
(Domcke et al., 2015). Together, these data show that DNA
methylation can act upstream of modified H3K27, likely by
means of modulating binding of DNA methylation-dependent
transcription factors.
Regulation of H3K27me3 Depends on 5-Methylcytosine
and DNMT Catalytic Activity
In understanding the relationship between DNA methylation
and histone modifications, it is important to distinguish be-
tween effects directly conferred by 5-methylcytosine (5mC),
DNMT-protein interactions, and other indirect effects. To test
whether the methylcytosine moiety of DNA itself or DNMT pro-
tein is responsible for re-establishing H3K27me3 at gene pro-
moters, we reconstituted a catalytically null mutant of Dnmt3b1
(Dnmt3b1MUT) that contains missense mutations in the essen-
tial PC motif in DKO mESCs. Promoter H3K27me3 in the recon-
stitution with catalytic mutant resembled DKO at both bivalent
and silent promoters. This demonstrates that the ability of
DNMT to re-establish H3K27me3 patterns in TKO and DKO
mESCs is dependent on DNMT catalytic activity and 5mC (Fig-
ures 5A and 5B). Similarly, at poised enhancer elements
gaining/losing H3K27me3, Dnmt3b1MUT is unable to rescue
H3K27me3 redistribution compared to wild-type Dnmt3b (Fig-
ure 5C). For example, Dnmt3b1MUT showed lack of regulation
of H3K27me3 at promoters of bivalent Cdkn2a and silent
Trpv1, as well as intragenic de novo poised enhancer in
Tmem104 and intergenic poised enhancer lost upstream of
Foxp4 (Figure 5D). This is consistent with a previous study of
Dnmt3a1 catalytic mutants in neural stem cells, which show
an inability to reverse PRC2/H3K27me3 occupancy (Wu et al.,
2010).pG ratio (bottom) in 2 kb surrounding enhancer center between categories of
een enhancer categories.
630-20,231,247) showing increase in H3K27ac at intronic enhancer (boxed and
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Figure 4. DNAMethylation Sensitive Regulatory El-
ements Include Both Tissue-Specific Promoters
and Enhancers
(A) Candidate enhancers gaining or losing H3K27ac/me3
upon DNA demethylation are cross-referenced to previ-
ously identified tissue-specific enhancers (Shen et al.,
2012). Tissues with candidate enhancer overlap >4% are
labeled, and all remaining tissues are grouped in ‘‘Other’’
category.
(B) DNA sequence motifs enriched in de novo DNA
methylation-dependent active and poised enhancer
categories.
(C) Examples of tissue-specific enhancers overlapping
differentially methylated regions and methylation-depen-
dent transcription factor motifs enriched in our analysis.
Genome browser tracks show enhancers upstream of
Zfp92 (chrX:70,622,988–70,673,292) and intragenic to
Ears2 (chr7:129,179,862–129,202,881). Whole-genome
bisulfite sequencing tracks are shown for mESC, adult
germline stem cell (AGSC) from testis, and placenta (Sta-
dler et al., 2011; Hammoud et al., 2014; Hon et al., 2013).DNA Methylation Regulation of H3K27me3 Is Mediated
by PRC2 Targeting
We have shown that both promoters and enhancers prone to
gaining H3K27me3 are heavily methylated in WT, consistent
with a direct antagonism between DNA methylation and
H3K27me3. To test whether this direct relationship extends
to the respective catalytic enzymes, we analyzed published
genome binding data of DNMT3A2, DNMT3B1, and SUZ12
(Baubec et al., 2015; Cooper et al., 2014). Similar to measure-
ments of DNA methylation profiles at promoters and enhancers,
we find that DNMT3A2 andDNMT3B1 are preferentially bound to
silent promoters and de novo poised enhancers that both gain
H3K27me3 in TKO (Figures 6A and 6B). Likewise, SUZ12 binding
mirrors H3K27me3 occupancy, where SUZ12 binding increases
at silent promoters in TKO (Cooper et al., 2014). In a similar
manner, SUZ12 increases strongly at de novo poised enhancers
(Figures 6A and 6B). The strong presence of DNMT and 5mC at
silent promoters and de novo poised enhancers that gain SUZ12296 Cell Reports 17, 289–302, September 27, 2016and H3K27me3 upon demethylation suggests
direct antagonism between DNA methylation
and PRC2 complex as previously described in
neural progenitor cells (NPCs) (Wu et al., 2010).
In contrast, bivalent promoters are unmethy-
lated and lack DNMT binding, implying an indi-
rect mechanism for regulating H3K27me3 and
PRC2.
Differences of Dnmt3a and Dnmt3b
Isoforms in Histone Modification
Regulation
For the two catalytically active de novo methyl-
transferases, multiple isoforms have been char-
acterized. These isoforms are expressed in a tis-
sue and developmentally regulated manner. In
mESCs, Dnmt3a2 and Dnmt3b1 are the major
isoforms, while Dnmt3a1 is expressed at a lower
level and increases in expression throughoutdevelopment (Chen et al., 2002; Feng et al., 2005). Methylation
patterns are determined through differential expression of
Dnmt3a and Dnmt3b isoforms (Chen et al., 2003) but are redun-
dant as certain targets, such as Oct4 and Nanog, are still able to
be methylated in single knockouts (Li et al., 2007). We therefore
asked whether different Dnmt3 isoforms have unique or shared
targets across the genome. Segmenting the genome into
500 bp windows, we found that the vast majority of methylated
windows (26M bases) can be methylated by all three isoforms
(90%). Interestingly, we identify a tiny fraction of the genome
(in total about 200 kb or <1%) that appear either Dnmt3a1 spe-
cific, Dnmt3a2 specific, or Dnmt3b1 specific. Therefore, the
three Dnmt3 isoforms have highly redundant genomic targets.
We next evaluated the effect on histone modifications by
different Dnmt isoforms. One challenge in measuring these dif-
ferences is the inherent lack of quantitative ability of conventional
ChIP-seq, precluding accurate and quantitative comparison be-
tween isoforms. We therefore compared histone modifications
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Figure 5. Regulation of H3K27me3 Depends on DNMT Catalytic Activity
(A) Heatmap of H3K4me3 (red) and H3K27me3 (blue) at ±5 kb region centered around all Refseq TSS ranked by H3K4me3. H3K27me3 compared between DKO,
DKO+Dnmt3b1 (wild-type), and DKO+Dnmt3b1MUT (catalytic mutant).
(B) Comparison of H3K27me3 occupancy between wild-type Dnmt3b1 and catalytic mutant reconstitution at bivalent and silent promoters. Average profile of
H3K27me3 across ±5 kb centered on TSS and quantification between cell lines shown for bivalent (top) and silent promoters (bottom).
(C) Comparison between reconstitution of wild-type Dnmt3b1 and Dnmt3b1MUT at enhancers. Metaplot showing average profiles of H3K27me3 occupancy
centered on de novo poised enhancers (top) and poised enhancers losing H3K27me3 (bottom).
(D) Genome browser tracks showing examples of H3K27me3 changes at promoters of Cdkn2a and Trpv1 as well as de novo poised enhancer in Tmem104 and
poised enhancer upstream of Foxp4 (chr17:48,106,091–48,116,091).between Dnmt reconstitution lines and performed comparison
with reference to background to account for systematic differ-
ences betweenChIP-seq libraries.We find that allDnmt isoforms
studied were able to regulate H3K27me3 and re-establish WT
patterns to some extent at promoters, indicating redundancy in
their function. This is also evident in the ability of Dnmt isoforms
to re-establish similar global methylation levels (Figure 1B). How-
ever, of the three enzymes, Dnmt3b1 reconstitution showed the
least recapitulation toward WT despite similar ability to remethy-
late the genome. Measuring the ratio of H3K27me3 occupancy
between Dnmt3 isoforms at bivalent promoters, we find that
Dnmt3a1 and Dnmt3a2 restore H3K27me3 to higher levels
than Dnmt3b1 (Figures S5A and S5B). Similarly, at silent pro-
moters, both Dnmt3a2 and Dnmt3a1 resuppress H3K27me3 to
a greater extent than Dnmt3b1 (Figures 2D, S5A, and S5B).
At enhancers, we found Dnmt3a1 and Dnmt3a2 show greater
recovery of H3K27me3 at poised enhancers losing H3K27me3and greater resuppression of H3K27me3 at de novo poised en-
hancers than Dnmt3b1 (Figures S5C and S5D). Likewise, com-
parison of H3K27ac changes between reconstitution lines
showed that both Dnmt3a2 and Dnmt3a1 restored WT patterns
more than Dnmt3b1 (Figure S5E). Overall, these comparisons
indicate a potential bias between Dnmt3a and Dnmt3b in the
regulation of histone modifications at promoters and enhancer
elements.
DISCUSSION
In the current study, we combined sequential genetic alteration
of DNA methylation levels with systematic and comprehensive
mapping of histone modifications to assess how DNA methyl-
ation influences the epigenomic and transcriptomic land-
scape. Our experiments show the active histone modification
H3K4me3 is deposited independently of DNA methylation, whileCell Reports 17, 289–302, September 27, 2016 297
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Figure 6. DNA Methylation Directly Regulates Loci Gaining H3K27me3 via PRC2 Occupancy
(A) Heatmap comparison of 5mC, DNMT3A2/B1, H3K27me3, and SUZ12 between different genomic contexts. Data are shown within ±5 kb centered on TSS or
center of enhancer and quantified as averaged depth-normalized tags in 100 bp bins.
(B) Metaplot profiles showing average occupancy of DNMT3A2/3B1 and SUZ12 across silent promoters (top) and de novo poised enhancers (bottom) (Baubec
et al., 2015; Cooper et al., 2014).DNA methylation acts upstream of H3K27me3, H3K27ac, and
H3K4me1, which have regulatory consequences at both gene
promoters and enhancers. Another key finding in our study
was the reversibility of the histone landscape in response to de-
methylation and newly established methylcytosine marks (Fig-
ure 7). Thus, DNA methylation is situated within a hierarchy of
epigenetic regulation where it is required for regulation of some
histone modifications.
Measurement of histone modifications showed different
responses to genome-wide demethylation. For example,
H3K4me3 did not change in response to global hypomethylation.
This is in contrast to somatic cells, where hypomethylation re-
sults in appearance of new H3K4me3 peaks, albeit far fewer
than H3K27me3 (Reddington et al., 2013). This indicates that
DNMT acts downstream of H3K4me3 in ESCs. The downstream
position of DNA methylation is consistent with mechanistic
studies of de novo methylation showing exclusion of DNMT
binding to sites marked with H3K4me3 (Noh et al., 2015; Ooi
et al., 2007; Otani et al., 2009; Zhang et al., 2010). H3K4me1
on the other hand showed moderate changes at promoters in
DnmtKO indicating sensitivity to DNAmethylation. Binding affin-
ity of H3K4me1 to DNMT3A-ADD and DNMT3L was over an or-
der of magnitude greater than H3K4me3, indicating methylation
states of H3K4 differ in their relationship with DNA methylation
(Noh et al., 2015; Ooi et al., 2007). H3K4me3 therefore belongs
to a list of histone modifications including H3K9me3 and
H3K36me3 that dictate DNMT localization in ESCs.
One model for the relationship between H3K27me3 and DNA
methylation is that EZH2 targets DNMT for de novo methylation.
The preferential de novo methylation at Polycomb targets in
many cancers lends credence to this notion (Gal-Yam et al.,
2008). EZH2 and DNMT1/3A/3B were shown to physically298 Cell Reports 17, 289–302, September 27, 2016interact, where EZH2 is required for DNMT binding at EZH2 tar-
gets in HeLa cells (Vire´ et al., 2006). Based on thismodel, DNMTs
would not influence H3K27me3 as PRC2 acts upstream of
DNMT. However, in contrast to this model, we find that loss of
DNA methylation affects the maintenance of H3K27me3 pat-
terns, which are then able to be re-established with DNMT
reconstitution, indicating that DNA methylation functionally
acts upstream of PRC2 activity in mESCs. DNA methylation
acting upstream of histone modifications is not unprecedented,
where DNA methylation has been shown to target H3K9 methyl-
transferase activity in fibroblasts (Fuks et al., 2003). Recently,
DNAmethylationwas found to recruit SETDB1 and consequently
H3K9me3 to key developmental genes in preadipocytes (Matsu-
mura et al., 2015). However, in ESCs, DNA methylation is
not required for H3K9me3 deposition (Karimi et al., 2011). These
differences could be due to intrinsic differences between
embryonic and somatic cells or particular cell states.
We found that the relationship between global DNA methyl-
ation and H3K27me3 is dependent on genomic context. The
negative correlation at silent promoter is consistent with the
antagonism between DNA methylation and H3K27me3 (Bartke
et al., 2010; Fouse et al., 2008; Mikkelsen et al., 2007). However,
the positive correlation at bivalent promoters is unexplained.
Bivalent promoters are unmethylated precluding a direct influ-
ence of methylcytosine on PRC2 at these sites. The leading
thought is that antagonism between DNA methylation and
PRC2 constrains H3K27me3 within CpG islands, which is lost
in TKO cells (Brinkman et al., 2012; Reddington et al., 2013). In
this case, in cells lacking DNA methylation, H3K27me3 is aber-
rantly deposited to regions normally restricted by DNA methyl-
ation, resulting in depletion of H3K27me3 at sites such as biva-
lent promoters. In other words, DNA demethylated regions act
Figure 7. DNA Methylation Reversibly Regulates Histone Modifica-
tions across Promoter and Enhancer Contexts
Schematic of DNA methylation shaping of the epigenome. At promoters (left)
hypomethylation results in loss or gain of H3K27me3, but not H3K4me3. Loss/
gain of H3K27me3 is associated with H3K4me3 occupancy, where bivalent
promoters marked by both H3K4me3 and H3K27me3 lose H3K27me3 with
hypomethylation, while silent promoters absent of histone modifications gain
H3K27me3 in the demethylated state. At enhancers (right) methylation re-
presses enhancers, which become poised (gain H3K27me3) or active (gain
H3K27ac) upon global demethylation. Reconstitution of DNMT in all contexts
re-establishes WT patterns.as a sink for PcG activity. Alternatively, PRC2 has been shown to
bind as a default state to CpG-rich DNA, while being obstructed
by active gene expression (Jermann et al., 2014; Riising et al.,
2014). DNA methylation could therefore influence gene expres-
sion of bivalent genes and consequently regulate H3K27me3.
The order of events between PRC2 binding and gene activity
are not yet known, preventing evaluation of such a mechanism.
It remains of great interest mechanistically how DNAmethylation
regulates H3K27me3 at bivalent promoters.
The relationship between DNA methylation and chromatin
state at enhancers has largely been based on association, with
little indication of order of events (Andersson et al., 2014; Elliott
et al., 2015; Hon et al., 2013; Ziller et al., 2013). Our data showing
de novo gain of H3K27me3 and H3K27ac at enhancers upon de-
methylation demonstrate DNA methylation’s regulation of chro-
matin state. This is in agreement with previous work showing
loss of H3K27ac resulting from hypermethylation by Tet2
knockout (Hon et al., 2014; Lu et al., 2014). Notably, our findings
showed reversibility of H3K27me3 and H3K27ac changes at
both promoters and enhancers. This indicates that DNA methyl-
ation can establish silent chromatin states, even over preexisting
active states.
At de novo active enhancers, DNAmethylation most likely reg-
ulates H3K27ac at active enhancers through modulation of tran-
scription factor binding. Recent results showedDNAmethylation
competes with binding of transcription factor NRF1, where
changes in NRF1 binding were reversible between 2i and Serum
conditions (Domcke et al., 2015). We identified the NRF1 binding
motif enriched at methylation-sensitive active enhancers, indi-
cating regulation of ‘‘settler’’ transcription factor binding as a
target of regulation by DNA methylation. We also identified mo-tifs for Kaiso, a factor that binds methylated CpG in vitro and re-
cruits deacetylation complex NCoR to repress gene expression
(Yoon et al., 2003). The huge diversity in transcription factors and
their individual relationships with DNA methylation represent
many potential mechanisms underlying methylation-dependent
changes in histone modifications. Several models describing
the relationship between DNAmethylation and transcription fac-
tors have been previously reviewed (Blattler and Farnham, 2013).
Similarly, poised enhancers showed reversible regulation by
DNA methylation. Studies support the idea that the three-
dimensional architecture of the genome is structured into dense
polycomb interfaces (so-called polycomb bodies), providing ev-
idence of higher-order interactions among H3K27me3 enriched
sites (Joshi et al., 2015; Li et al., 2015; Wani et al., 2016). It re-
mains to be seen whether DNA methylation can control higher-
order interactions via regulation of histone modifications and
other structural proteins.
Another question in the field that lacks understanding is what
differences exist between Dnmt isoforms. Early evidence sug-
gested strong redundancy between isoforms in ESCs as single
gene knockouts of either Dnmt3a or Dnmt3b showed minimal
changes in DNA methylation (Chen et al., 2003; Okano et al.,
1999). Knockdown of Dnmt isoforms revealed hypermethylation
of highly transcribed gene bodies upon Dnmt3b knockdown,
whereas Dnmt3a knockdown resulted in global hypomethylation
(Tiedemann et al., 2014). DNMT3B was also found to selectively
localize to gene bodies of highly transcribed genes through
H3K36me3, while DNMT3A showed decreased methylation of
highly transcribed genes (Baubec et al., 2015). In our results,
we find a dominant role for Dnmt3a isoforms over Dnmt3b in
re-establishing H3K27me3 patterns at both promoters and en-
hancers. This provides some clues that differential expression
of Dnmt isoforms may play a role in regulating chromatin state
and gene expression, but much still remains to be studied.
In sum, this research provides a comprehensive resource to-
ward the understanding of how alterations in DNA methylation
sculpt the rest of the epigenome. Our results present a model
where DNAmethylation plays an active role in establishing chro-
matin states in addition to its classic role in gene silencing via
promoter CpG methylation. Thus, in the cascade of epigenetic
gene regulation, DNAmethylation serves as a multifaceted regu-
lator, acting on both DNA and chromatin in the mammalian
genome.EXPERIMENTAL PROCEDURES
ESC Culture
Mouse embryonic stem cells (mESCs) were grown on irradiatedmouse embry-
onic fibroblasts (MEFs) andmaintained in DMEM (Corning) supplemented with
15% fetal bovine serum, 1 mMGlutaMAX (Life Technologies), 13 non-essen-
tial amino acids (NEAA), 13 penicillin/streptomycin (Life Technologies), mLIF,
and 0.001% a^-mercaptoethanol (Sigma-Aldrich).ChIP-Seq and Analysis
ChIP-seq libraries were constructed using Kapa Library Preparation Kit for
Illumina sequencing (Kapa Biosystems). Libraries were pooled and sequenced
using the Illumina HiSeq machine as either 50 or 100-bp single-end seq-
uencing reads. Sequenced reads were mapped to mouse genome (mm9) us-
ing bowtie 1.1.0 allowing up to two mismatches and only unique alignments.Cell Reports 17, 289–302, September 27, 2016 299
Mapped reads were processed using Homer tool suite (Heinz et al., 2010). For
details, see the Supplemental Experimental Procedures.
Reduced Representation Bisulfite Sequencing and Analysis
Genomic DNA was purified from mESCs using standard phenol-chloroform-
isoamyl alcohol extraction followed by ethanol precipitation. Libraries were
generated as previously described with minor modification (Meissner et al.,
2005). Libraries were pooled and sequenced using the Illumina HiSeqmachine
as 100-bp single-end sequencing reads. Reads were mapped to the mouse
genome (mm9) with Bismark (Krueger and Andrews, 2011). For details, see
the Supplemental Experimental Procedures.
RNA-Seq and Analysis
Total RNA was purified using RNeasy Mini Kit (QIAGEN). Poly(A)-tailed RNA
was purified from total RNA and libraries were constructed using the TruSeq
RNA Library Prep Kit v.2.0 (Illumina). Libraries were pooled and sequenced us-
ing the Illumina HiSeq machine as 100-bp single-end sequencing reads.
Reads were mapped to the mouse genome (mm9) with STAR aligner (Dobin
et al., 2013). For details, see the Supplemental Experimental Procedures.
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